Literature DB >> 3326632

The large studies in hypertension: what have they shown?

J I Robertson1.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3326632      PMCID： PMC1386202          DOI： 10.1111/j.1365-2125.1987.tb03262.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  19 in total

1.  The risk-benefit equation: when to initiate treatment.

Authors:  J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 2.  The use of beta blockers for the reduction of mortality after myocardial infarction.

Authors:  J R Hampton
Journal:  Eur Heart J       Date:  1981-08       Impact factor: 29.983

3.  Ventricular extrasystoles during thiazide treatment.

Authors:  P A Poole-Wilson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

4.  A decade of progress in the management of hypertension.

Authors:  M Moser
Journal:  Hypertension       Date:  1983 Nov-Dec       Impact factor: 10.190

5.  Conflicting clinical trials and the uncertainty of treating mild hypertension.

Authors:  P J Toth; R I Horwitz
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

6.  Sounding board. Should mild hypertension be treated?

Authors:  E D Freis
Journal:  N Engl J Med       Date:  1982-07-29       Impact factor: 91.245

7.  Cardiovascular and adrenergic effects of cigarette smoking during immediate non-selective and selective beta adrenoceptor blockade in humans.

Authors:  J Trap-Jensen; J E Carlsen; T L Svendsen; N J Christensen
Journal:  Eur J Clin Invest       Date:  1979-06       Impact factor: 4.686

8.  Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

Authors:  A Hjalmarson; D Elmfeldt; J Herlitz; S Holmberg; I Málek; G Nyberg; L Rydén; K Swedberg; A Vedin; F Waagstein; A Waldenström; J Waldenström; H Wedel; L Wilhelmsen; C Wilhelmsson
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

9.  Coronary heart-disease after treatment of hypertension.

Authors:  G Berglund; R Sannerstedt; O Andersson; H Wedel; L Wilhelmsen; L Hansson; R Sivertsson; J Wikstrand
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

10.  A long-term prevention study with oxprenolol in coronary heart disease.

Authors:  S H Taylor; B Silke; A Ebbutt; G C Sutton; B J Prout; D M Burley
Journal:  N Engl J Med       Date:  1982-11-18       Impact factor: 91.245
View more
  5 in total

1.  Should the costs of development inhibit research into new antihypertensive drugs?

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

2.  Vasodilatation in hypertension: the relevance of ISA. Concluding paper.

Authors:  A Zanchetti
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

Review 3.  Angiotensin converting enzyme inhibitors and moderate hypertension.

Authors:  D McAreavey; J I Robertson
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

4.  A long-term study on the effect of pindolol on serum lipoproteins: a preliminary report.

Authors:  L A Carlson; M Ribacke; A Terent
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

Review 5.  The case for antihypertensive drug treatment in subjects over the age of 60.

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.